Short answer · Medically reviewed summary · Last updated: 2026-04-07
The prevalence of porphyria is difficult to determine precisely due to significant underdiagnosis, but estimates for the most common form, Porphyria Cutanea Tarda (PCT), range from 1 in 5,000 to 1 in 25,000 people globally. Other types, such as Acute Intermittent Porphyria (AIP), are rarer, with a symptomatic prevalence estimated at approximately 1 to 5 per 100,000 individuals depending on the geographic population. Is porphyria considered a rare disease? While some forms of porphyria are relatively common in specific populations, the group of disorders is generally classified as rare.
2 people with Porphyria have shared their first-person experience on this question at DiseaseMaps.
What is the prevalence of Porphyria?
Prevalence of Porphyria: how many people are affected worldwide, differences by sex and region, with sources.
The prevalence of porphyria is difficult to determine precisely due to significant underdiagnosis, but estimates for the most common form, Porphyria Cutanea Tarda (PCT), range from 1 in 5,000 to 1 in 25,000 people globally. Other types, such as Acute Intermittent Porphyria (AIP), are rarer, with a symptomatic prevalence estimated at approximately 1 to 5 per 100,000 individuals depending on the geographic population.
Is porphyria considered a rare disease?
While some forms of porphyria are relatively common in specific populations, the group of disorders is generally classified as rare. Because porphyria encompasses eight distinct metabolic conditions, each with different genetic and environmental triggers, the global prevalence varies significantly. Many individuals carry the genetic predisposition for a specific type of porphyria but remain asymptomatic throughout their lives, which complicates efforts to establish accurate incidence and prevalence statistics.
What factors influence the prevalence and diagnosis of porphyria?
Accurate epidemiological data for porphyria are hampered by several clinical challenges, including the condition's complex presentation and the frequent overlap of symptoms with more common gastrointestinal or neurological disorders. The following factors contribute to the difficulty in gathering precise statistics:
- Underdiagnosis: Many patients with mild or latent porphyria never seek medical attention or are never tested.
- Misdiagnosis: Symptoms like abdominal pain or skin sensitivity are often attributed to other conditions, leading to significant delays in identifying porphyria.
- Genetic Penetrance: Even when a genetic mutation is present, not every individual will develop clinical symptoms, meaning clinical prevalence is often lower than the true genetic carrier rate.
- Geographic and Ethnic Variation: Certain types of porphyria, such as Variegate Porphyria, show higher prevalence in specific populations (e.g., the South African Afrikaner population) due to a founder effect.
How does age and gender impact porphyria diagnosis?
The age of onset for porphyria varies widely depending on the specific subtype. Acute hepatic porphyrias typically manifest after puberty, with symptoms most frequently appearing in young adulthood (ages 20 to 40). Conversely, cutaneous forms may present in childhood or later in life depending on environmental triggers like sun exposure. Regarding gender, while genetic mutations for porphyria are often inherited in an autosomal dominant pattern, clinical symptoms are frequently reported more often in females, though this may be influenced by hormonal factors and better access to diagnostic screening.
What does the DiseaseMaps community data tell us?
At DiseaseMaps.org, we have 289 people with porphyria who have joined the community to share their experiences. This real-world, patient-centered data provides an invaluable perspective that complements clinical literature. By connecting with others, patients often find that their journey—from initial symptoms to eventual diagnosis—mirrors the experiences of many others who struggled to find answers due to the rarity of the condition. This community serves as a vital bridge between scientific estimates and the daily reality of living with this complex metabolic disorder.
Next steps
- Consult a metabolic specialist or a hematologist if you suspect you have symptoms of porphyria.
- Request specialized diagnostic testing, such as urine, stool, or blood porphyrin profiles, through a physician familiar with rare metabolic diseases.
- Join the DiseaseMaps.org community to connect with peers and access shared resources for disease management.
- Visit the American Porphyria Foundation or the European Porphyria Network for updated clinical guidelines and expert-led webinars.
Medical disclaimer: This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment; always seek the guidance of a qualified healthcare provider regarding a medical condition.
References
- Orphanet: Rare Disease Database (orpha.net)
- NIH Genetic and Rare Diseases (GARD) Information Center (rarediseases.info.nih.gov)
- Online Mendelian Inheritance in Man (OMIM)
- American Porphyria Foundation (porphyriafoundation.org)
Posted Mar 30, 2019 by Marie 2500
Throughout the world, over 100 mutations have been shown to result in defective protoporphyrinogen oxidase activity and variegate porphyria. One mutation, the R59W mutation, represents the founder mutation in the South African population, and accounts for approximately 95% of all patients with variegate porphyria in South Africa. Testing for the R59W mutation is therefore a useful diagnostic test in the South African population. At least nine other mutations are found in South Africa
Researchers in South Africa were able to trace the disease to the founding family. Gerrit Jansz van Deventer came to the Cape of Good Hope & subsequently married Ariaantje Jacobs on the 29th October 1688. South Africa Pedigrees have traced the start of porphyria in South Africa to these two individuals. They had eight children, four of whom suffered from porphyria. Researchers have been unable to determine which of the two individuals had the condition- perhaps they both had Variegate Porphyria.
Women tend to suffer more attacks because of the hormonal fluctuations, especially during pregnancy or a monthly period.
Biochemical testing - Biochemical tests (urine or stool porphyrin testing) is usually done after puberty as the characteristic biochemical features of AIP, VP, PCT and HCP, like the clinical features, only appear to manifest thereafter, usually from the age of 16-20 onwards.
Posted Jun 1, 2021 by Carollynn 5770
